Compare OMCL & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMCL | LMAT |
|---|---|---|
| Founded | 1992 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | 2000 | 2006 |
| Metric | OMCL | LMAT |
|---|---|---|
| Price | $36.44 | $83.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $57.86 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 416.9K | 215.1K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | 0.77 | ★ 1.42 |
| Revenue | ★ $787,309,000.00 | $249,602,000.00 |
| Revenue This Year | $4.40 | $10.79 |
| Revenue Next Year | $4.12 | $9.54 |
| P/E Ratio | ★ $47.49 | $58.67 |
| Revenue Growth | 9.93 | ★ 13.53 |
| 52 Week Low | $29.09 | $78.22 |
| 52 Week High | $51.84 | $118.01 |
| Indicator | OMCL | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.65 | 56.05 |
| Support Level | $35.25 | $82.58 |
| Resistance Level | $37.64 | $88.54 |
| Average True Range (ATR) | 1.15 | 2.25 |
| MACD | 0.18 | 0.40 |
| Stochastic Oscillator | 78.35 | 81.26 |
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.